Synthetic Biology Market Size To Reach $69.18 Billion By 2033

January 2026 | Report Format: Electronic (PDF)

Synthetic Biology Market Growth & Trends

The global synthetic biology market size is expected to reach USD 69.18 billion by 2033, registering a CAGR of 17.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.

Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), DOD, FDA, and others (formerly OWS).

Other factors such as expanding demand in industries such as textiles and nutrition are also contributing to the market growth. Several optimal food production processes have been identified with the help of synthetic biology. In addition, synthetic biology is predicted to aid in the generation of higher agricultural yields and pest control development. It is expected to help in the production of better food yield and pest control management.

The COVID-19 pandemic is anticipated to positively impact market growth. Synthetic biology has been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S. Therefore, synthetic biology labs and companies have been actively utilizing this technology to combat the COVID-19 pandemic. As a result, the usage of these technologies is projected to increase during the outbreak.

The growing demand for personalized medicine is expected to majorly drive market growth during the coming years. The use of engineered novel proteins for use as therapeutics has demonstrated synthetic biology in the medical segment. These proteins are designed with some modified protein structure to get the desirable properties required for the treatment. For instance, researchers are developing a therapeutic enzyme candidate that is GI-stable and can be given via oral route to treat Phenylketonuria (PKU).

On the other hand, synthetic biology has raised a few concerns regarding biosecurity and biosafety. Exposure to these products may cause unknown hazards to public health and the environment. To prevent such issues, countries of Europe, the Americas, and Asia have formulated policies to manage the application of synthetic biology techniques in basic & applied research.

key Request a free sample copy or view report summary: Synthetic Biology Market Report

Synthetic Biology Market Report Highlights

Technological progress in genetic engineering remains a primary growth driver for the synthetic biology market, fundamentally reshaping how biological systems are designed, engineered, and commercialized.
The integration of digital tools and AI-assisted design is emerging as a critical driver of growth in the synthetic biology market, significantly improving efficiency, accuracy, and scalability across development workflows
The enzymes segment dominated the market in 2025 with a share of 36.78%. Enzymes play essential role in various biotechnological processes, including DNA manipulation, protein engineering, and metabolic pathway construction.
The PCR segment accounted for the largest market share of 30.21% in 2025, and this trend is expected to persist during the forecast period.
The healthcare segment led the synthetic biology market in 2025, driven by its crucial role in developing advanced therapies and diagnostics
The biotechnology and pharmaceutical companies segment captured the largest revenue share of 54.70% in 2025, driven by its central role in advancing medical innovations and therapeutic solutions..
North America synthetic biology market accounted for the largest market share of 42.10% in 2025, driven by strong investment from both public and private sectors, including significant funding from venture capital and government initiatives